Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Tanaka, T.
Right arrow Articles by Mori, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanaka, T.
Right arrow Articles by Mori, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 23, No. 8, 1361-1367, August 2002
© 2002 Oxford University Press


MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Modifying effects of dietary capsaicin and rotenone on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis

Takuji Tanaka1,3, Hiroyuki Kohno1, Keiko Sakata2, Yasuhiro Yamada2, Yoshinobu Hirose2, Shigeyuki Sugie2 and Hideki Mori2

1 Department of Pathology, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Ishikawa 920-0293 and
2 Department of Pathology, 40 Tsukasa-machi, Gifu 500-8705, Japan

The effects of dietary administration of capsaicin and rotenone on 4-nitroquinoline 1-oxide (4-NQO)-induced tongue tumorigenesis were investigated in male F344 rats. In pilot studies, gavage with capsaicin and rotenone elevated the phase II enzymes glutathione S-transferase (GST) and quinone reductase (QR), in the liver and tongue. Also, a 10 week period of feeding of 500 p.p.m. capsaicin or rotenone together with 4-NQO exposure inhibited the occurrence of tongue dysplasia. Subsequently, a long-term study was conducted to test the protective effects of both compounds on 4-NQO-induced tongue carcinogenesis. One group was treated with 4-NQO alone (20 p.p.m. in drinking water for 8 weeks) and four other groups received the carcinogen treatment plus diets containing 500 p.p.m. test compounds for 10 weeks (initiation phase) or for 28 weeks (post-initiation phase). At the termination of the study (38 weeks), feeding of rotenone during the initiation phase, but not during the post-initiation phase, was found to significantly reduce the incidence of tongue squamous cell carcinoma (53% vs. 16%, 70% reduction, P b=e 0.0250) and severe dysplasia (80% vs. 42%, 70% reduction, P = 0.028). Capsaicin feeding during either the initiation or promotion phase and rotenone feeding during the promotion phase also reduced the frequency of tongue carcinoma without statistical significance. The treatment with two compounds especially rotenone lowered cell proliferation activity in the tongue, elevated phase II enzymes’ activities of the liver and tongue, and increased the apoptotic index of tongue carcinoma. Although our results suggest that rotenone feeding during the initiation stage prevented 4-NQO-induced tongue carcinoma, chronic intravenous exposure of rotenone reproduces several features of human Parkinson’s disease in rats (Nat. Neurosci., 3, 1301–1306, 2000), suggesting that additional studies to confirm the safety of rotenone are warranted.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Bhutani, A. K. Pathak, A. S. Nair, A. B. Kunnumakkara, S. Guha, G. Sethi, and B. B. Aggarwal
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6-Inducible STAT3 Activation
Clin. Cancer Res., May 15, 2007; 13(10): 3024 - 3032.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Hartel, F F di Mola, F Selvaggi, G Mascetta, M N Wente, K Felix, N A Giese, U Hinz, P Di Sebastiano, M W Buchler, et al.
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management
Gut, April 1, 2006; 55(4): 519 - 528.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S.-Y. Sun, N. Hail Jr, and R. Lotan
Apoptosis as a Novel Target for Cancer Chemoprevention
J Natl Cancer Inst, May 5, 2004; 96(9): 662 - 672.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
X.-H. Tang, B. Knudsen, D. Bemis, S. Tickoo, and L. J. Gudas
Oral Cavity and Esophageal Carcinogenesis Modeled in Carcinogen-Treated Mice
Clin. Cancer Res., January 1, 2004; 10(1): 301 - 313.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.